Radiopharm Theranostics Ltd (RADX) Form 6-K — Jul 27, 2026
Radiopharm Theranostics Ltd announced a registered direct offering of 1,281,646 American Depositary Shares at a price of $3.16 per share to raise approximately $4.1 million in gross proceeds. The offering includes unregistered warrants for investors to purchase the same number of shares at an exercise price of $3.79, expiring on July 31, 2029. In addition to the US offering, the company secured firm commitments for about A$6.7 million from Australian institutional investors and initiated a Share Purchase Plan for eligible shareholders to raise up to an additional A$6 million.
Key figures
- Gross Proceeds
- approximately US$4.1 million
- Offering Price
- $3.16
- Shares Offered
- 1,281,646
- Warrant Expiry
- July 31, 2029
- Options Exercise Price
- A$0.018
- Share Purchase Plan Max
- A$6 million (US$4.2 million)
- Warrant Exercise Price
- US$3.79
- Australian Placement Gross
- approximately A$6.7 million (US$4.7 million)
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.